Page last updated: 2024-09-04

moxifloxacin and nocathiacin i

moxifloxacin has been researched along with nocathiacin i in 1 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (nocathiacin i)	Trials (nocathiacin i)	Recent Studies (post-2010) (nocathiacin i)
3,157	552	1,690	27	0	8

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kreiswirth, BN; Kurepina, N; Meinke, PT; Olsen, DB; Singh, SB; Xu, L; Young, K	1

Other Studies

1 other study(ies) available for moxifloxacin and nocathiacin i

Article	Year
Thiazomycin, nocathiacin and analogs show strong activity against clinical strains of drug-resistant Mycobacterium tuberculosis. The Journal of antibiotics, 2017, Volume: 70, Issue:5 Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Intercellular Signaling Peptides and Proteins; Isoniazid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Peptides; Peptides, Cyclic; Rifampin; Solubility; Thiazoles	2017

Article

Year

Thiazomycin, nocathiacin and analogs show strong activity against clinical strains of drug-resistant Mycobacterium tuberculosis.

The Journal of antibiotics, 2017, Volume: 70, Issue:5

Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Intercellular Signaling Peptides and Proteins; Isoniazid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Peptides; Peptides, Cyclic; Rifampin; Solubility; Thiazoles

2017